Home » Newsletters » BioWorld Science

BioWorld Science

June 4, 2009

View Archived Issues

SASP PT1.2 reduces antibiotic resistance and retains activity when co-applied with other antibiotics

Novel serine/threonine kinase inhibitors discovered by Schering-Plough for cancer treatment

Wyeth presents novel Raf kinase B inhibitors for cancer treatment

Sanofi-aventis presents novel GHS receptor antagonists for the treatment of obesity

GlaxoSmithKline describes novel monoamine reuptake inhibitors as antidepressants

CP-751871 combined with chemotherapy shows promise in phase II trial in NSCLC patients

ITMN-520 prevents airway hyper-responsiveness in murine model of allergen-induced airway dysfunction

EpiCept partners with IDIS for compassionate use Ceplene program

Swissmedic grants approval for clinical study of Neovacs' TNFalpha-kinoid

Pfizer launches Toviaz and YourWay support plan for overactive bladder patients in the U.S.

FDA advisory committee to review ISTA's NDA for Bepreve in June 2009

HHS awards contract to MedImmune to make nasal spray vaccine for H1N1

Celldex enters into definitive agreement to acquire CuraGen

AstraZeneca and Merck & Co. collaborate on novel combination anticancer regimen

Atlantic Healthcare receives EMEA orphan drug status for alicaforsen in pouchitis

NIM-811 may benefit the liver after massive hepatectomy

Cleveland BioLabs concludes initial phase I safety study for CBLB-502

Lilly resubmits Cymbalta supplemental NDA to FDA for chronic pain

Biken launches dry cell-cultured Japanese encephalitis vaccine Jebik V

Phase I results encourage continued study of TRU-016 in chronic lymphocytic leukemia

Clinical study points to oncolytic activity of PF-02341066 in ALK-dependent tumors

TorreyPines Therapeutics' Board of Directors approves of plan of liquidation

AJM-300 benefits some Crohn's disease patients in double-blind trial

NCI initiates phase II clinical trial of Rigel's oral Syk inhibitor R-788 in multiple cancers

Antiinfective Drugs Advisory Committee completes review of ALS' Restanza for CAP

Nuvigil launched for sleepiness associated with several sleeping disorders

Genzyme receives positive CHMP opinion for Mozobil in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...